Gadoxetic acid contrast distinguising benign arterial hyperenhancement of cirrhosis versus HCC. (A) On the subtracted late arterial phase Gadoxetic acid enhanced study there are 2 areas of hyperenhancement (black and white arrows); (B) The hepatobiliary phase from the same exam the shows the low signal area of the HCC (black arrow) but the normal hepatic uptake and therefore normal signal intensity in hepatic segment IV (white arrow), consistent with benign vascular shunting. Subsequent exams (not shown) demonstrated the loss of the segment IV arterial contrast enhancement with the continued presence of normal hepatic uptake in this area.